Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36961| Title: | Antenatal Medical Therapies to Improve Lung Development in Congenital Diaphragmatic Hernia. | Authors: | Russo F.M.;Polglase G.;Deprest J.;Hodges R.;Hooper S.;Kashyap A.;Dekoninck P.;Crossley K.;Thio M. | Institution: | (Kashyap, Dekoninck, Crossley, Polglase, Hooper, Hodges) Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia (Kashyap, Dekoninck, Crossley, Polglase, Hooper, Hodges) Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia (Thio) Newborn Research Centre, Royal Women's Hospital, Melbourne, Australia (Thio) Centre of Research Excellence in Newborn Medicine, Murdoch Children's Research Institute, Melbourne, Australia (Thio) Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia (Thio) PIPER - Neonatal Retrieval Services Victoria, Royal Children's Hospital, Melbourne, Australia (Russo, Deprest) Division of Woman and Child, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium (Russo, Deprest) Department of Development and Regeneration, Cluster Woman and Child, Faculty of Medicine, KU Leuven, Belgium (Deprest) Institute for Women's Health, University College London Hospital, London, United Kingdom (Hodges) Monash Women's Service, Monash Health, Melbourne, Australia | Issue Date: | 23-Jul-2018 | Copyright year: | 2018 | Publisher: | Thieme Medical Publishers, Inc. (E-mail: custserv@thieme.com) | Place of publication: | United States | Publication information: | American Journal of Perinatology. 35 (9) (pp 823-836), 2018. Date of Publication: 01 Jul 2018. | Journal: | American Journal of Perinatology | Abstract: | Congenital diaphragmatic hernia (CDH) is a birth defect characterized by failed closure of the diaphragm, allowing abdominal viscera to herniate into the thoracic cavity and subsequently impair pulmonary and vascular development. Despite improving standardized postnatal management, there remains a population of severe CDH for whom postnatal care falls short. In these severe cases, antenatal surgical intervention (fetoscopic endoluminal tracheal occlusion [FETO]) may improve survival; however, FETO increases the risk of preterm delivery, is not widely offered, and still fails in half of cases. Antenatal medical therapies that stimulate antenatal pulmonary development are therefore interesting alternatives. By presenting the animal research underpinning novel antenatal medical therapies for CDH, and considering the applications of these therapies to clinical practice, this review will explore the future of antenatal CDH management with a focus on the phosphodiesterase-5 inhibitor sildenafil.Copyright © 2018 by Thieme Medical Publishers, Inc. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1055/s-0037-1618603 | PubMed URL: | 29341044 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29341044] | ISSN: | 0735-1631 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/36961 | Type: | Review | Type of Clinical Study or Trial: | Review article (e.g. literature review, narrative review) |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.